Interestingly, previous studies on inflammatory bowel disease and liver inflammation had demonstrated the suppressing effect of the PXR on NF-κB activity (Deuring et al., 2019; Okamura et al., 2020), suggesting the anti-inflammatory effect of the PXR. The gene discussed is NR1I2; the disease is inflammatory bowel disease.